Building A US Business: Celltrion’s New CCO Talks Strategy
Biosimilars Specialist Moves To Direct Sales Model In US With Three Key Launches
With Celltrion transitioning to a direct sales model in the US after previously partnering with other firms to market its biosimilars, the company’s new US chief commercial officer, Tom Nusbickel, talks to Generics Bulletin about how the firm is gearing up to launch three key products.
